Abhinav Nath

2.3k total citations
51 papers, 1.8k citations indexed

About

Abhinav Nath is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Abhinav Nath has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in Abhinav Nath's work include Pharmacogenetics and Drug Metabolism (16 papers), Protein Structure and Dynamics (10 papers) and Drug Transport and Resistance Mechanisms (10 papers). Abhinav Nath is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Protein Structure and Dynamics (10 papers) and Drug Transport and Resistance Mechanisms (10 papers). Abhinav Nath collaborates with scholars based in United States, Mexico and India. Abhinav Nath's co-authors include William M. Atkins, Stephen G. Sligar, Elizabeth Rhoades, Andrew D. Miranker, Matthew F. Calabrese, Yong Xiong, Leslie S. Wolfe, Rachel E. Klevit, Hannah E.R. Baughman and William M. Atkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Abhinav Nath

47 papers receiving 1.8k citations

Peers

Countries citing papers authored by Abhinav Nath

Since Specialization

Citations

This map shows the geographic impact of Abhinav Nath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhinav Nath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhinav Nath more than expected).

Fields of papers citing papers by Abhinav Nath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhinav Nath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhinav Nath. The network helps show where Abhinav Nath may publish in the future.

Co-authorship network of co-authors of Abhinav Nath

This figure shows the co-authorship network connecting the top 25 collaborators of Abhinav Nath. A scholar is included among the top collaborators of Abhinav Nath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhinav Nath. Abhinav Nath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rigorous Analysis of Multimodal HDX-MS Spectra 2025 ·Journal of the American Society for Mass Spectrometry ·Lisa M. Tuttle, (unknown), Florian Georgescauld, Thomas E. Wales, David D. Weis, John R. Engen, Abhinav Nath, Rachel E. Klevit, Miklós Guttman	4
2	Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review 2024 ·Drug Metabolism Reviews ·(unknown), (unknown), (unknown), Abhinav Nath, Rheem A. Totah	0
3	The origins of nonideality exhibited by monoclonal antibodies and Fab fragments in human serum 2023 ·Protein Science ·(unknown), William M. Atkins, Abhinav Nath	1
4	Low molecular weight ligands bind to CYP3A4 via a branched induced fit mechanism: Implications for O2 binding 2023 ·Archives of Biochemistry and Biophysics ·(unknown), Abhinav Nath, John C. Hackett, William M. Atkins	0
5	MitoNEET’s Reactivity of Lys55 toward Pyridoxal Phosphate Demonstrates its Activity as a Transaminase Enzyme 2022 ·ACS Chemical Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhinav Nath, Werner J. Geldenhuys, Michael A. Menze, (unknown)	4
6	Release of a disordered domain enhances HspB1 chaperone activity toward tau 2020 ·Proceedings of the National Academy of Sciences ·Hannah E.R. Baughman, (unknown), (unknown), Abhinav Nath, Rachel E. Klevit	41
7	Membrane Disruption and Peptide/Lipid Co-Assembly by the Amyloid-Forming Peptide, PAP248-286 2020 ·Biophysical Journal ·(unknown), Abhinav Nath	1
8	Interplay of disordered and ordered regions of a human small heat shock protein yields an ensemble of ‘quasi-ordered’ states 2019 ·eLife ·Amanda F. Clouser, Hannah E.R. Baughman, Benjamin Basanta, Miklós Guttman, Abhinav Nath, Rachel E. Klevit	41
9	HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation 2018 ·Journal of Biological Chemistry ·Hannah E.R. Baughman, Amanda F. Clouser, Rachel E. Klevit, Abhinav Nath	73
10	Comparing Antibody-Antigen Binding in Serum Versus Buffer with Fluorescence Correlation Spectroscopy 2017 ·Biophysical Journal ·(unknown), (unknown), Abhinav Nath	0
11	Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2 2017 ·British Journal of Ophthalmology ·(unknown), Travis Smith, Paul Yang, (unknown), Allan E. Rettie, Abhinav Nath, Richard G. Weleber, Edward J. Kelly	17
12	A functional role for intrinsic disorder in the tau-tubulin complex 2016 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Shana Elbaum‐Garfinkle, Abhinav Nath, Elizabeth Rhoades	64
13	In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation 2016 ·Biochemical Pharmacology ·Jennifer E. Sager, Sasmita Tripathy, Lauren Price, Abhinav Nath, (unknown), Alyssa Stephenson‐Famy, Nina Isoherranen	31
14	Folded Small Molecule Manipulation of Islet Amyloid Polypeptide 2014 ·Chemistry & Biology ·Sunil Kumar, (unknown), Abhinav Nath, Andrew D. Miranker	23
15	A Membrane‐Bound Antiparallel Dimer of Rat Islet Amyloid Polypeptide 2011 ·Angewandte Chemie International Edition ·Abhinav Nath, Andrew D. Miranker, Elizabeth Rhoades	36
16	Quantifying and Predicting the Promiscuity and Isoform Specificity of Small-Molecule Cytochrome P450 Inhibitors 2010 ·Drug Metabolism and Disposition ·Abhinav Nath, Michael Zientek, Benjamin J. Burke, Ying Jiang, William M. Atkins	16
17	Single-Molecule Fluorescence Spectroscopy Using Phospholipid Bilayer Nanodiscs 2010 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Abhinav Nath, Adam Trexler, Peter K. Koo, Andrew D. Miranker, William M. Atkins, Elizabeth Rhoades	49
18	Principal Component Analysis of CYP2C9 and CYP3A4 Probe Substrate/Inhibitor Panels 2008 ·Drug Metabolism and Disposition ·Abhinav Nath, William M. Atkins	5
19	Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4 2008 ·Archives of Biochemistry and Biophysics ·Abhinav Nath, Cristina Fernández, Jed N. Lampe, William M. Atkins	14
20	Ligand Binding to Cytochrome P450 3A4 in Phospholipid Bilayer Nanodiscs 2007 ·Journal of Biological Chemistry ·Abhinav Nath, Yelena V. Grinkova, Stephen G. Sligar, William M. Atkins	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact